Pacira BioSciences, Inc. PCRX Business Segments — Legal settlement
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LitigationSettlementLoss.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — legal settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — legal settlement?
- Pacira BioSciences, Inc. (PCRX) reported business segments — legal settlement of $0 in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — legal settlement changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — legal settlement decreased by 100.0% year-over-year, from $7M to $0.
- What does business segments — legal settlement mean?
- Captures the financial impact of legal settlements or litigation-related costs specifically attributed to the operations of the reportable segment. This metric highlights non-recurring financial risks and potential liabilities arising from legal disputes.